Advik Laboratories last traded at ₹2.08 (2026-10-13). Over the past month the stock moved +4.5%, three months the stock moved +20.2%, year the stock moved +0.5%. Its closing range over 52 weeks is ₹1.65 – ₹2.08, with the latest close at its 52-week high.
Closing prices up to 2026-10-13.
Incorporated in 1997, MPS Pharmaa Ltd manufactures and sells pharmaceutical products[1]
Business Overview:[1] a) MPSPL (Formerly Advik Laboratories Ltd) is in the business of manufacturing, marketing, trading, and export of Pharma Products. b) The company has its manufacturing facility at Sohna. c) It has various independent contract /third-party manufacturers based across the country
In the latest quarter (Jun 2026), Advik Laboratories reported sales of ₹0.00 crore and net profit of ₹-0.24 crore, compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 0.00 | -0.20 | – | -0.24 | -0.13 |
| Mar 2026 | 0.00 | -0.37 | – | -0.36 | -0.19 |
| Dec 2025 | 0.00 | -0.19 | – | -0.22 | -0.12 |
| Sep 2025 | 0.00 | -0.19 | – | -0.22 | -0.12 |
| Jun 2025 | 0.00 | -0.19 | – | -0.22 | -0.12 |
| Mar 2025 | 0.00 | -0.19 | – | -0.28 | -0.15 |
| Dec 2024 | 0.00 | -0.18 | – | -0.17 | -0.09 |
| Sep 2024 | 0.00 | -0.19 | – | -0.22 | -0.12 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | – | – | – | – | – | – | – | – |
| Operating profit growth | – | – | – | – | – | – | – | – |
| Net profit growth | – | – | – | – | – | – | – | – |
| EPS growth | – | – | – | – | – | – | – | – |
| OPM % | – | – | – | – | – | – | – | – |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), Advik Laboratories reported sales of ₹0.00 crore and net profit of ₹-1.02 crore, compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 0.00 | -0.95 | – | -1.02 | -0.53 |
| Mar 2025 | 0.00 | -0.77 | – | -0.90 | -0.47 |
| Mar 2024 | 0.00 | -0.80 | – | -0.83 | -0.43 |
| Mar 2023 | 0.00 | -0.95 | – | -1.05 | -0.55 |
| Mar 2022 | 0.03 | -0.68 | -2,266.67 | -0.14 | -0.07 |
| Mar 2021 | 0.00 | -4.14 | – | -4.42 | -2.31 |
| Mar 2020 | 0.00 | -0.67 | – | -1.17 | -0.61 |
| Mar 2019 | 0.83 | -0.73 | -87.95 | -1.25 | -0.65 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -79.7% | -100.0% | – | – | -100.0% | – | – | – |
| Operating profit growth | – | – | – | – | – | – | – | – |
| Net profit growth | – | – | – | – | – | – | – | – |
| EPS growth | – | – | – | – | – | – | – | – |
| OPM % | -88.0% | – | – | -2266.7% | – | – | – | – |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Advik Laboratories.
Get Free AI Stock Analysis FREE →No recent news available for Advik Laboratories.
Advik Laboratories shares were last quoted at ₹2.08 (+0.0% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Advik Laboratories has a price-to-earnings (P/E) ratio of -3.85 and a price-to-book (P/B) ratio of 0.00. The industry P/E is 53.45.
The 52-week high of Advik Laboratories is ₹2.08 and the 52-week low is ₹1.57.
The market capitalisation of Advik Laboratories is about ₹3.98 crore.
In the latest quarter (Jun 2026), Advik Laboratories reported sales of ₹0.00 crore and net profit of ₹-0.24 crore, compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, Advik Laboratories has a 3-year ROE of -61.00%, 3-year profit growth of 1.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 35.89% of Advik Laboratories.
Advik Laboratories belongs to the Pharmaceuticals & Drugs sector.